# Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)

> **NCT00002395** · PHASE2 · COMPLETED · sponsor: **SmithKline Beecham** · enrollment: 54 (—)

## Conditions studied

- HIV Infections
- Leukoencephalopathy, Progressive Multifocal

## Interventions

- **DRUG:** Topotecan

## Key facts

- **NCT ID:** NCT00002395
- **Lead sponsor:** SmithKline Beecham
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 54 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002395, "Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*